Related Experiment Video
Updated: Mar 7, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
An Unusual Occurrence of Methicillin Resistant Staphylococcal Endocarditis with Vancomycin Creep Phenomenon - A
S Sneha1, Shanthan Venishetty2, Shubha Seshadri3
1Assistant Professor, Department of Internal Medicine, Kasturba Medical College , Manipal, Karnataka, India .
Abstract:
Infective endocarditis by Methicillin Resistant Staphylococcus aureus (MRSA) bacteraemia is a common association and carries a high mortality. However, rising Minimum Inhibitory Concentrations (MICs) for vancomycin amongst MRSA strains is an emerging threat which carries poor prognosis and higher mortality. Here, we report a case of 41-year-old young non-addict gentleman presenting with fever of 3 days duration following recovery from an acute kidney injury necessitating haemodialysis. Systemic examination revealed signs of mitral regurgitation and left sided cerebellar signs. Laboratory investigations revealed anaemia, MRSA bacteraemia and transthoracic echocardiogram showed a mitral valve vegetation. He was diagnosed with MRSA mitral valve endocarditis with acute left cerebellar infarct. He was initially treated with intravenous vancomycin based on MIC at the dose of one gram every twelfth hourly. As the MRSA strain was shown to demonstrate a vancomycin creep phenomemon along with worsening clinical condition of the patient, treatment was changed to intravenous daptomycin at dose of 9mg/kg as per blood culture and sensitivity pattern which was administered for 6 weeks. Following initiation of daptomycin patient became afebrile and vegetations reduced in size and finally disappeared.
Insights
This case study highlights a Methicillin-Resistant Staphylococcus aureus (MRSA) endocarditis infection. Daptomycin effectively treated the infection when vancomycin resistance emerged, showcasing an alternative treatment for challenging MRSA cases.
Area of Science:
- Infectious Diseases
- Cardiology
- Nephrology
Background:
- Infective endocarditis caused by Methicillin-Resistant Staphylococcus aureus (MRSA) is associated with high mortality.
- Increasing vancomycin Minimum Inhibitory Concentrations (MICs) in MRSA strains present a growing clinical challenge with poor prognosis.
- This case involves a patient with MRSA bacteraemia and mitral valve endocarditis, complicated by acute kidney injury requiring hemodialysis.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Development of Antibiotic Resistance
Antibiotic Selection

